After several weeks of range-bound movement, shares in Arkema could enter into a new clear trend. The exit out of the current trading range could be the signal for a return of volatility.
Summary
● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● The company presents an interesting fundamental situation from a short-term investment perspective.
● The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● With regards to fundamentals, the enterprise value to sales ratio is at 0.68 for the current period. Therefore, the company is undervalued.
● The company appears to be poorly valued given its net asset value.
● The company has a low valuation given the cash flows generated by its activity.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Weaknesses
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company's earnings growth outlook lacks momentum and is a weakness.
● Over the past four months, analysts' average price target has been revised downwards significantly.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Arkema is one of the world's leaders in the development, manufacturing and marketing of chemical products. Net sales break down by family of products as follows:
- advanced materials (37.4%): high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, etc.;
- adhesives (28.5%): sealants, adhesives for floors and tiles, waterproofing products, etc.;
- coating solutions (25.3%): resins, emulsions for adhesives, surface coating products, absorbents, etc.;
- intermediate products (8.4%): thermoplastic polymers (PMMA), acrylic products, fluorinated gases, etc.;
- other (0.4%).
At the end of 2023, the group had 148 production sites worldwide.
Net sales are distributed geographically as follows: France (7.8%), Europe (26.6%), United States-Canada-Mexico (36.5%), China (11%), Asia (12.6%) and others (5.5% ).